Results 61 to 70 of about 41,059 (214)

Differences in clinicopathologic variables between Borrelia C6 antigen seroreactive and Borrelia C6 seronegative glomerulopathy in dogs. [PDF]

, 2019
BackgroundRapidly progressive glomerulonephritis has been described in dogs that seroreact to Borrelia burgdorferi, but no studies have compared clinicopathologic differences in Lyme-seroreactive dogs with protein-losing nephropathy (PLN) versus dogs ...
Goldstein RE, Grauer GF, Kalish RA, Levy S, Levy SA, Rolla D, Scorpio DG   +6 more
core   +1 more source

Ethics of Personalised Medicine: Importance of the Multidisciplinary Approach in KidneySign Project

PROTEOMICS, EarlyView.
ABSTRACT This article explores the ethical and societal issues in developing personalised medicine (PM) as part of the KidneySign project, which aims to mobilise translational big data to validate a proteomic signature of renal fibrosis with prognostic value.
Delphine Azéma, Flore Duranton, Àngel Argilés, Emmanuelle Rial‐Sebbag   +3 more
wiley   +1 more source

Initial and Recurrent Hyperkalemia Events in Patients With CKD in Older Adults: A Population-Based Cohort Study

Canadian Journal of Kidney Health and Disease, 2021
Background: The risk of hyperkalemia is elevated in chronic kidney disease (CKD); however, the initial and recurrent risk among older individuals is less clear.
Sriram Sriperumbuduri, Eric McArthur, Gregory L. Hundemer, Mark Canney, Navdeep Tangri, Silvia J. Leon, Sara Bota, Ann Bugeja, Ayub Akbari, Greg Knoll, Manish M. Sood   +10 more
doaj   +1 more source

The effectiveness and safety of azvudine treatment in COVID‐19 patients with kidney disease based on a multicenter retrospective cohort study

VIEW, EarlyView.
A retrospective, multicenter cohort study was conducted across nine hospitals in Henan Province, aiming to evaluate the efficacy and safety of azvudine in hospitalized COVID‐19 patients with kidney disease. Through the application of Kaplan‒Meier and multivariate Cox regression analyses, it was found that azvudine may have potential effects in reducing
Bo Yu, Mengzhao Yang, Jia Yu, Daming Wang, Hong Luo, Ming Cheng, Shixi Zhang, Guotao Li, Ling Wang, Guowu Qian, Donghua Zhang, Silin Li, Zhigang Ren, Quancheng Kan   +13 more
wiley   +1 more source

Outcomes in Older Inpatients with Hyperkalemia: A Follow-up Observational Study

Journal of the Indian Academy of Geriatrics
Objectives: Hyperkalemia is a common electrolyte disturbance encountered in hospitalized older patients secondary to age-related physiological changes in the kidneys, multiple comorbidities, and the burden of multiple medication usage. Metabolic acidosis,
Bharathi Ramesh, Reuben Jerrald Felix, Surekha Viggeswarpu, Antonisamy Belavendra   +3 more
doaj   +1 more source

Clinical Significance and Management of Atrioventricular Block Associated With Bradycardic/Antiarrhythmic Drug Therapy: Drug‐Induced or Drug‐Revealed?

Journal of Cardiovascular Electrophysiology, EarlyView.
Schematic representation of the management pathway in drug‐related advanced atrioventricular block. ABSTRACT The development of advanced atrioventricular block (AVB) in patients on bradycardic and/or antiarrhythmic therapy (drug‐related AVB) represents a clinical challenge, raising the question of whether the AVB is directly caused by these agents ...
Dimitrios Sfairopoulos, George Bazoukis, Skevos Sideris, Nikolaos Fragakis, Konstantinos Letsas, Konstantinos Zekios, Tong Liu, Panagiotis Korantzopoulos   +7 more
wiley   +1 more source

Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest [PDF]

, 2017
BACKGROUND: Hyperkalemia is a common electrolyte abnormality and has well-recognized early electrocardiographic manifestations including PR prolongation and symmetric T wave peaking.
Abhijeet Dhoble, Adrian DaSilva-DeAbreu, Luke Masha, Shareez Peerbhai   +3 more
core   +1 more source

The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors have been shown to improve renal and cardiovascular outcomes in patients with type 2 diabetes. Limited evidence exists about the efficacy and safety of SGLT2 inhibitors in patients with frailty. Methods This was a post hoc pooled, participant‐level data analysis of the CANVAS Program
Tu N. Nguyen, Jie Yu, Vlado Perkovic, Meg Jardine, Kenneth W. Mahaffey, Clara K. Chow, Clare Arnott, Richard I. Lindley   +7 more
wiley   +1 more source

An unusual manifestation of hyperkalemia

Pan African Medical Journal, 2014
An 82 years old patient was admitted to the emergency department complaining since 15 days of fatigue, dizziness and lipothymia. He had a history of hypertension and diabetes; and had undergone a coronary bypass in 2005. His physical examination showed a blood pressure at 160/50mmHg, a heart rate at 26cycles/min, and he was afebrile.
Ahmed Belkouch, Lahcen Belyamani
openaire   +5 more sources

Pseudohyperkalemia Revisited: An Updated Review of a Foremost Preanalytical Error of Serum or Plasma Potassium Measurement in the Clinical Laboratory

Nigerian Journal of Medicine
Background: Potassium is one of the most abundant cations in the human body. Increased plasma potassium concentration (hyperkalemia) is one of the most common electrolyte abnormalities in contemporary clinical practice.
Henry Chima Okpara, Emeka Callistus Onyeka Izuchukwu, E. C. Ilechukwu   +2 more
doaj   +1 more source